Nutrisystem Inc. (NASDAQ:NTRI) has received a consensus rating of “Buy” from the seven analysts that are currently covering the company. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $36.14.

A number of equities analysts have commented on the stock. Argus initiated coverage on shares of Nutrisystem in a research note on Friday, November 11th. They issued a “buy” rating and a $40.00 price target for the company. B. Riley reaffirmed a “buy” rating and issued a $41.00 price objective on shares of Nutrisystem in a research note on Monday, October 24th. Barrington Research upped their price objective on shares of Nutrisystem from $35.00 to $37.00 and gave the company an “outperform” rating in a research note on Monday, October 31st. Zacks Investment Research raised shares of Nutrisystem from a “hold” rating to a “buy” rating and set a $35.00 price objective for the company in a research note on Saturday, October 29th. Finally, Wunderlich upped their price objective on shares of Nutrisystem from $31.00 to $37.00 and gave the company a “buy” rating in a research note on Wednesday, October 19th.

In related news, CFO Michael P. Monahan sold 10,000 shares of the company’s stock in a transaction on Friday, November 11th. The shares were sold at an average price of $34.34, for a total transaction of $343,400.00. Following the completion of the sale, the chief financial officer now directly owns 43,712 shares in the company, valued at approximately $1,501,070.08. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Dawn M. Zier sold 19,150 shares of the company’s stock in a transaction on Thursday, October 20th. The shares were sold at an average price of $31.15, for a total transaction of $596,522.50. Following the sale, the insider now owns 241,321 shares of the company’s stock, valued at $7,517,149.15. The disclosure for this sale can be found here. Corporate insiders own 2.90% of the company’s stock.

A number of large investors have recently bought and sold shares of NTRI. BlackRock Group LTD raised its stake in Nutrisystem by 8.2% in the first quarter. BlackRock Group LTD now owns 40,297 shares of the company’s stock worth $840,000 after buying an additional 3,042 shares in the last quarter. Panagora Asset Management Inc. raised its stake in Nutrisystem by 86.4% in the first quarter. Panagora Asset Management Inc. now owns 245,592 shares of the company’s stock worth $5,126,000 after buying an additional 113,808 shares in the last quarter. BNP Paribas Arbitrage SA raised its stake in Nutrisystem by 99.7% in the second quarter. BNP Paribas Arbitrage SA now owns 9,586 shares of the company’s stock worth $243,000 after buying an additional 4,787 shares in the last quarter. Capstone Asset Management Co. raised its stake in Nutrisystem by 20.0% in the second quarter. Capstone Asset Management Co. now owns 16,246 shares of the company’s stock worth $412,000 after buying an additional 2,710 shares in the last quarter. Finally, James Investment Research Inc. raised its stake in Nutrisystem by 36.6% in the second quarter. James Investment Research Inc. now owns 114,955 shares of the company’s stock worth $2,915,000 after buying an additional 30,770 shares in the last quarter. Institutional investors own 96.19% of the company’s stock.

Nutrisystem (NASDAQ:NTRI) remained flat at $36.10 during midday trading on Thursday. The company’s stock had a trading volume of 74,712 shares. The company has a market cap of $1068.52 billion, a P/E ratio of 35.05 and a beta of 0.87. The stock has a 50 day moving average price of $31.61 and a 200-day moving average price of $28.26. Nutrisystem has a 12 month low of $17.25 and a 12 month high of $37.35.

Nutrisystem (NASDAQ:NTRI) last released its quarterly earnings results on Wednesday, October 26th. The company reported $0.27 EPS for the quarter, topping the Zacks’ consensus estimate of $0.26 by $0.01. Nutrisystem had a net margin of 5.78% and a return on equity of 43.89%. The business earned $124.60 million during the quarter, compared to analysts’ expectations of $238.36 million. During the same quarter in the previous year, the company earned $0.25 EPS. The business’s quarterly revenue was up 18.8% compared to the same quarter last year. On average, analysts anticipate that Nutrisystem will post $1.13 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 17th. Investors of record on Monday, November 7th will be issued a dividend of $0.175 per share. The ex-dividend date is Thursday, November 3rd. This represents a $0.70 dividend on an annualized basis and a yield of 1.94%. Nutrisystem’s dividend payout ratio is currently 67.96%.

About Nutrisystem

Nutrisystem, Inc (Nutrisystem) is a provider of weight management products and services, including nutritionally balanced weight loss programs, multi-day kits available at retail locations and digital tools to support weight loss. The Company’s program customers purchase monthly food packages containing four-week meal plan consisting supply of breakfasts, lunches, dinners and snacks and flex meal plan recipes, which they supplement with fresh fruits, vegetables and dairy.

5 Day Chart for NASDAQ:NTRI

Receive News & Stock Ratings for Nutrisystem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrisystem Inc. and related stocks with our FREE daily email newsletter.